Apoptosis and chemotherapy resistanceLeukemia. 1999, Vol 13, Num 11, pp 1853-1892, issn 0887-6924Conference Proceedings

Cytotoxic drugs and the CD95 pathway : Apoptosis and Chemotherapy ResistanceFRIESEN, C; FULDA, S; DEBATIN, K.-M et al.Leukemia. 1999, Vol 13, Num 11, pp 1854-1858, issn 0887-6924Conference Paper

Apoptosis and chemotherapy resistanceHICKMAN, J. A.European journal of cancer (1990). 1996, Vol 32, Num 6, pp 921-926, issn 0959-8049Article

Drug-induced apoptosis in chronic lymphocytic leukemia : Apoptosis and Chemotherapy ResistanceSTOETZER, O. J; POGREBNIAK, A; SCHOLZ, M et al.Leukemia. 1999, Vol 13, Num 11, pp 1873-1880, issn 0887-6924Conference Paper

New system for assessing the prognosis of refractory anemia patientsMATSUDA, A; JINNAI, I; MATSUO, T et al.Leukemia. 1999, Vol 13, Num 11, pp 1727-1734, issn 0887-6924Conference Paper

Chronic myeloid leukemia from basics to bedsideTHIJSEN, S. F. T; SCHUURHUIS, G. J; VAN OOSTVEEN, J. W et al.Leukemia. 1999, Vol 13, Num 11, pp 1646-1674, issn 0887-6924Conference Paper

Expression of p16^INK4A and p14^ARF in hematological malignanciesTANIGUCHI, T; CHIKATSU, N; TAKAHASHI, S et al.Leukemia. 1999, Vol 13, Num 11, pp 1760-1769, issn 0887-6924Conference Paper

Detection of MUM1/IRF4-IgH fusion in multiple myelomaYOSHIDA, S; NAKAZAWA, N; IIDA, S et al.Leukemia. 1999, Vol 13, Num 11, pp 1812-1816, issn 0887-6924Conference Paper

Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines : Apoptosis and Chemotherapy ResistanceNUESSLER, V; STÖTZER, O; GULLIS, E et al.Leukemia. 1999, Vol 13, Num 11, pp 1864-1872, issn 0887-6924Conference Paper

Expression of Bcl-2-related genes in normal and AML progenitors : changes induced by chemotherapy and retinoic acid : Apoptosis and Chemotherapy ResistanceANDREEFF, M; JIANG, S; ESTEY, E. H et al.Leukemia. 1999, Vol 13, Num 11, pp 1881-1892, issn 0887-6924Conference Paper

The role of Homeobox genes in normal hematopoiesis and hematological malignanciesVAN OOSTVEEN, J. W; BIJL, J. J; RAAPHORST, F. M et al.Leukemia. 1999, Vol 13, Num 11, pp 1675-1690, issn 0887-6924Conference Paper

FISH analysis for BCL-1 rearrangements and trisomy 12 helps the diagnosis of atypical B cell leukaemiasMATUTES, E; CARRARA, P; COIGNET, L et al.Leukemia. 1999, Vol 13, Num 11, pp 1721-1726, issn 0887-6924Conference Paper

Frequent allelic imbalance but infrequent microsatellite instability in gastric lymphomaHOEVE, M. A; FERREIRA MOTA, S. C; SCHUURING, E et al.Leukemia. 1999, Vol 13, Num 11, pp 1804-1811, issn 0887-6924Conference Paper

Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) : a clinicopathological studyTHIELE, J; KVASNICKA, H. M; BOELTKEN, B et al.Leukemia. 1999, Vol 13, Num 11, pp 1741-1748, issn 0887-6924Conference Paper

Molecular analysis of chromosomal breakpoints in three examples of chromosomal translocation involving the TEL geneROMANA, S. P; POIREL, H; DELLA VALLE, V et al.Leukemia. 1999, Vol 13, Num 11, pp 1754-1759, issn 0887-6924Conference Paper

The Tel-PDGFRβ fusion gene produces a chronic myeloproliferative syndrome in transgenic miceRITCHIC, K. A; APRIKYAN, A. A. G; BOWEN-POPE, D. F et al.Leukemia. 1999, Vol 13, Num 11, pp 1790-1803, issn 0887-6924Conference Paper

Molecular effects of topoisomerase II inhibitors in AML cell lines : correlation of apoptosis with topoisomerase II activity but not with DNA damage : Apoptosis and Chemotherapy ResistanceGIESELER, F; BAUER, E; NUESSLER, V et al.Leukemia. 1999, Vol 13, Num 11, pp 1859-1863, issn 0887-6924Conference Paper

Clinical relevance of minimal residual disease monitoring in non-Hodgkin's lymphomas : a critical reappraisal of molecular strategiesCORRADINI, P; LADETTO, M; PILERI, A et al.Leukemia. 1999, Vol 13, Num 11, pp 1691-1695, issn 0887-6924Conference Paper

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cellsGAZITT, Y.Leukemia. 1999, Vol 13, Num 11, pp 1817-1824, issn 0887-6924Conference Paper

Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalitiesMATHEW, S; BEHM, F. G; DALTON, J et al.Leukemia. 1999, Vol 13, Num 11, pp 1713-1720, issn 0887-6924Conference Paper

Quantitation of leukemia clone-specific antigen gene rearrangements by a single-step PCR and fluorescence-based detection methodMAYER, S. P; GIAMELLI, J; SANDOVAL, C et al.Leukemia. 1999, Vol 13, Num 11, pp 1843-1852, issn 0887-6924Conference Paper

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCREMIG, M; SAUSSELE, S; WITTOR, H et al.Leukemia. 1999, Vol 13, Num 11, pp 1825-1832, issn 0887-6924Conference Paper

Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD)OLSSON, K; GERARD, C. J; ZEHNDER, J et al.Leukemia. 1999, Vol 13, Num 11, pp 1833-1842, issn 0887-6924Conference Paper

Forced expression of the leukemia-associated gene EVI1 in ES cells : a model for myeloid leukemia with 3q26 rearrangementsSITAILO, S; SOOD, R; BARTON, K et al.Leukemia. 1999, Vol 13, Num 11, pp 1639-1645, issn 0887-6924Conference Paper

Selective pressure as an essential force in molecular evolution of myeloid leukemic clones : a view from the window of Fanconi anemiaLENSCH, M. W; RATHBUN, R. K; OLSON, S. B et al.Leukemia. 1999, Vol 13, Num 11, pp 1784-1789, issn 0887-6924Conference Paper